X-152766934-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_005363.5(MAGEA6):āc.717C>Gā(p.Phe239Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00042 in 1,208,878 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 158 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00021 ( 0 hom., 5 hem., cov: 21)
Exomes š: 0.00044 ( 0 hom. 153 hem. )
Consequence
MAGEA6
NM_005363.5 missense
NM_005363.5 missense
Scores
2
1
4
Clinical Significance
Conservation
PhyloP100: -5.12
Genes affected
MAGEA6 (HGNC:6804): (MAGE family member A6) This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10921419).
BP6
Variant X-152766934-G-C is Benign according to our data. Variant chrX-152766934-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 2367566.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEA6 | NM_005363.5 | c.717C>G | p.Phe239Leu | missense_variant | 3/3 | ENST00000329342.10 | NP_005354.1 | |
MAGEA6 | NM_175868.4 | c.717C>G | p.Phe239Leu | missense_variant | 3/3 | NP_787064.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEA6 | ENST00000329342.10 | c.717C>G | p.Phe239Leu | missense_variant | 3/3 | 1 | NM_005363.5 | ENSP00000329199.5 | ||
MAGEA6 | ENST00000616035.4 | c.717C>G | p.Phe239Leu | missense_variant | 3/3 | 5 | ENSP00000480637.1 | |||
MAGEA6 | ENST00000457643.1 | c.*10C>G | downstream_gene_variant | 3 | ENSP00000401806.1 |
Frequencies
GnomAD3 genomes AF: 0.000215 AC: 24AN: 111679Hom.: 0 Cov.: 21 AF XY: 0.000148 AC XY: 5AN XY: 33893
GnomAD3 genomes
AF:
AC:
24
AN:
111679
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
33893
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000441 AC: 484AN: 1097145Hom.: 0 Cov.: 30 AF XY: 0.000422 AC XY: 153AN XY: 362555
GnomAD4 exome
AF:
AC:
484
AN:
1097145
Hom.:
Cov.:
30
AF XY:
AC XY:
153
AN XY:
362555
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000215 AC: 24AN: 111733Hom.: 0 Cov.: 21 AF XY: 0.000147 AC XY: 5AN XY: 33957
GnomAD4 genome
AF:
AC:
24
AN:
111733
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
33957
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
CADD
Benign
DEOGEN2
Benign
T;T
LIST_S2
Benign
.;T
MetaRNN
Benign
T;T
PROVEAN
Pathogenic
D;.
Sift
Benign
T;.
Sift4G
Uncertain
D;D
Vest4
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at